[Review: clinical outcome after living donor liver transplantation in patients with hepatitis C virus-associated cirrhosis]

Korean J Hepatol. 2007 Dec;13(4):489-94. doi: 10.3350/kjhep.2007.13.4.489.

[Article in Korean]

Author

Hyung Joon Kim¹

Affiliation

¹ Department of Internal Medicine, Chungang University College of Medicine, Seoul, Korea.

PMID: 18159146
DOI: 10.3350/kjhep.2007.13.4.489

No abstract available

Publication types

Editorial
Review
Comment

MeSH terms

Drug Therapy, Combination
Hepacivirus
Hepatitis C, Chronic / complications
Hepatitis C, Chronic / diagnosis*
Hepatitis C, Chronic / therapy
Humans
Interferon alpha-2
Interferon-alpha / therapeutic use
Liver Cirrhosis / diagnosis*
Liver Cirrhosis / mortality
Liver Cirrhosis / virology
Liver Transplantation*
Living Donors
Polyethylene Glycols / therapeutic use
Recombinant Proteins
Ribavirin / therapeutic use
Severity of Illness Index
Treatment Outcome

Substances

Interferon alpha-2
Interferon-alpha
Recombinant Proteins
Polyethylene Glycols
Ribavirin
peginterferon alfa-2a